Literature DB >> 24726464

SAPHO syndrome in an adolescent: a clinical case with unusual severe systemic impact.

Sílvia Freira1, Helena Fonseca2, Pedro Dias Ferreira1, Pedro Vasconcelos3, João Eurico Fonseca4.   

Abstract

SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome includes both dermatological and rheumatologic symptoms. Being a rare condition, the diagnosis is frequently late. The authors report a case of a 13-year-old boy diagnosed with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome with unusual severe systemic repercussions. The patient presented with acne conglobata, inability to walk due to pain and weakness and weight loss. Bone scintigraphy was suggestive of sacroiliitis, and lumbar spine x-ray showed signs of hyperostosis. His clinical state improved after treatment with nonsteroidal anti-inflammatory drugs, methotrexate, clindamycin, and isotretinoin. A review of the clinical aspects of this syndrome is presented, emphasizing how this underdiagnosed syndrome can lead to severe weight loss and significant functional and psychological impairment at an early age.
Copyright © 2014 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acne conglobata; Adolescent; Hyperostosis; Osteitis; SAPHO

Mesh:

Substances:

Year:  2014        PMID: 24726464     DOI: 10.1016/j.jadohealth.2014.02.004

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  2 in total

1.  SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report.

Authors:  Michele Luzzati; Gabriele Simonini; Cesare Filippeschi; Teresa Giani; Sandra Trapani
Journal:  Ital J Pediatr       Date:  2020-11-13       Impact factor: 2.638

2.  Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome Diagnosis in Adolescent and Isotretinoin as a Possible Serious Exacerbating Factor.

Authors:  Omar O Shahada; Ahmed S Kurdi; Afnan F Aljawi; Lujain I Khayat; Anas O Shahadah
Journal:  Cureus       Date:  2022-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.